[go: up one dir, main page]

PL3210991T3 - Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie - Google Patents

Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie

Info

Publication number
PL3210991T3
PL3210991T3 PL17166118T PL17166118T PL3210991T3 PL 3210991 T3 PL3210991 T3 PL 3210991T3 PL 17166118 T PL17166118 T PL 17166118T PL 17166118 T PL17166118 T PL 17166118T PL 3210991 T3 PL3210991 T3 PL 3210991T3
Authority
PL
Poland
Prior art keywords
levoisovalerylspiramycin
preparations
crystalline form
preparation methods
preparation
Prior art date
Application number
PL17166118T
Other languages
English (en)
Inventor
Yang Jiang
Xiaofeng Zhao
Original Assignee
Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Fuyang Pharmaceutical Technology Co., Ltd. filed Critical Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Publication of PL3210991T3 publication Critical patent/PL3210991T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
PL17166118T 2010-05-25 2011-05-25 Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie PL3210991T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CN201010182111 2010-05-25
CN201010182108 2010-05-25
CN201010182109 2010-05-25
EP11786085.8A EP2578595B1 (en) 2010-05-25 2011-05-25 Crystalline levoisovalerylspiramycin i
EP17166118.4A EP3210991B1 (en) 2010-05-25 2011-05-25 Crystalline form of levoisovalerylspiramycin ii and preparations, preparation methods and uses thereof
PCT/CN2011/074644 WO2011147313A1 (zh) 2010-05-25 2011-05-25 左旋异戊酰螺旋霉素i、ii或iii，及其制剂、制备方法及应用

Publications (1)

Publication Number Publication Date
PL3210991T3 true PL3210991T3 (pl) 2020-03-31

Family

ID=45003321

Family Applications (3)

Application Number Title Priority Date Filing Date
PL11786085T PL2578595T3 (pl) 2010-05-25 2011-05-25 Krystaliczna lewoizowalerylospiramycyna I
PL17166117T PL3210990T3 (pl) 2010-05-25 2011-05-25 Lewoizowalerylospiramycyna III i jej preparaty, sposoby wytwarzania i zastosowania
PL17166118T PL3210991T3 (pl) 2010-05-25 2011-05-25 Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL11786085T PL2578595T3 (pl) 2010-05-25 2011-05-25 Krystaliczna lewoizowalerylospiramycyna I
PL17166117T PL3210990T3 (pl) 2010-05-25 2011-05-25 Lewoizowalerylospiramycyna III i jej preparaty, sposoby wytwarzania i zastosowania

Country Status (16)

Country Link
US (1) US8778896B2 (pl)
EP (3) EP3210991B1 (pl)
JP (1) JP5945868B2 (pl)
KR (2) KR20130041829A (pl)
BR (1) BR112012029913B1 (pl)
CA (3) CA2800021C (pl)
DK (3) DK3210990T3 (pl)
ES (3) ES2633723T3 (pl)
MX (1) MX340626B (pl)
MY (1) MY164231A (pl)
PH (1) PH12012502323A1 (pl)
PL (3) PL2578595T3 (pl)
PT (1) PT3210990T (pl)
RU (3) RU2647237C1 (pl)
WO (1) WO2011147313A1 (pl)
ZA (3) ZA201209738B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2633737T3 (es) * 2010-05-25 2017-09-25 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Levocarrimicina, composiciones farmacéuticas, procedimientos de preparación y utilizaciones de la misma
CN105497053B (zh) * 2015-12-31 2018-02-13 沈阳福洋医药科技有限公司 可利霉素在抗结核分枝杆菌感染中的应用
JP7060631B2 (ja) * 2017-07-04 2022-04-26 沈陽福洋医薬科技有限公司 腫瘍を治療および／または予防する薬物の調製におけるイソバレリルスピラマイシンｉ、ｉｉおよび／またはｉｉｉの応用、ならびに薬物
US20200405739A1 (en) * 2018-01-19 2020-12-31 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Mtor inhibitor, pharmaceutical composition and use thereof
EP3741373B1 (en) 2018-01-19 2022-10-12 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Use of carrimycin or active ingredient thereof
CN110384710B (zh) * 2018-04-17 2023-01-10 沈阳福洋医药科技有限公司 一种用于预防和/或治疗疼痛的药物、组合产品及其应用
MX2020010938A (es) * 2018-04-17 2021-01-29 Shanghai Tonglian Pharmaceutical Co Ltd Medicamento para prevenir y/o tratar el dolor y/o la fiebre, producto compuesto y uso del mismo.
CN111939168B (zh) * 2019-05-16 2023-02-03 沈阳福洋医药科技有限公司 一种用于预防、缓解和/或治疗纤维化的药物、组合产品及其应用
CN112239483B (zh) * 2019-07-18 2023-10-27 沈阳福洋医药科技有限公司 一种化合物及药物组合物
US11351185B2 (en) 2020-03-11 2022-06-07 Asclea Corporation Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5334788A (en) * 1976-09-11 1978-03-31 Sanraku Inc Antibiotics spiramycin derivatives
CN1058295C (zh) 1997-06-03 2000-11-08 中国医学科学院医药生物技术研究所 一种利用基因工程技术制造生技霉素的方法
CN1169947C (zh) * 2002-11-19 2004-10-06 中国医学科学院医药生物技术研究所 必特螺旋霉素的基因工程菌株螺旋霉素链霉菌wsj-195
CN1237976C (zh) * 2003-12-23 2006-01-25 沈阳同联集团有限公司 必特螺旋霉素及其在抗感染性疾病中的应用
JP2008509899A (ja) * 2004-08-12 2008-04-03 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 胃腸管の炎症性疾患治療用の細胞特異的コンジュゲートの使用
CN101054553A (zh) * 2007-04-09 2007-10-17 中国医学科学院医药生物技术研究所 异戊酰螺旋霉素i基因工程菌株的构建
CN101649325B (zh) * 2009-07-03 2011-09-07 中国医学科学院医药生物技术研究所 一种提高基因工程异戊酰螺旋霉素主组分含量的基因串连技术
CN101785778A (zh) 2010-03-09 2010-07-28 沈阳同联集团有限公司 异戊酰螺旋霉素i的分离制备及其应用
CN101785779B (zh) 2010-03-09 2014-03-05 沈阳同联集团有限公司 异戊酰螺旋霉素ii的分离制备
CN101773510B (zh) * 2010-03-09 2013-06-05 沈阳同联集团有限公司 异戊酰螺旋霉素iii的分离制备
ES2633737T3 (es) * 2010-05-25 2017-09-25 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Levocarrimicina, composiciones farmacéuticas, procedimientos de preparación y utilizaciones de la misma

Also Published As

Publication number Publication date
EP3210990A1 (en) 2017-08-30
MX2012013470A (es) 2013-03-18
CA2915222C (en) 2019-03-12
DK2578595T3 (en) 2017-07-10
ES2781425T3 (es) 2020-09-02
ES2633723T3 (es) 2017-09-25
RU2647236C1 (ru) 2018-03-14
EP2578595A1 (en) 2013-04-10
DK3210991T3 (da) 2019-11-11
MX340626B (es) 2016-07-18
PT3210990T (pt) 2020-04-01
BR112012029913A2 (pt) 2017-11-28
JP2013528166A (ja) 2013-07-08
EP2578595A4 (en) 2013-11-06
BR112012029913A8 (pt) 2018-01-09
CA2800021C (en) 2016-03-22
ES2754614T3 (es) 2020-04-20
RU2647237C1 (ru) 2018-03-14
ZA201406382B (en) 2015-12-23
EP3210991A1 (en) 2017-08-30
US8778896B2 (en) 2014-07-15
KR101706518B1 (ko) 2017-02-14
RU2012156420A (ru) 2014-06-27
KR20160017124A (ko) 2016-02-15
EP3210990B1 (en) 2020-01-01
CA2915236A1 (en) 2011-12-01
ZA201209738B (en) 2015-04-29
CA2915236C (en) 2019-03-12
CA2915222A1 (en) 2011-12-01
MY164231A (en) 2017-11-30
RU2593498C2 (ru) 2016-08-10
EP3210991B1 (en) 2019-08-07
WO2011147313A1 (zh) 2011-12-01
JP5945868B2 (ja) 2016-07-13
EP2578595B1 (en) 2017-04-19
CA2800021A1 (en) 2011-12-01
PH12012502323A1 (en) 2023-03-10
PL2578595T3 (pl) 2017-10-31
US20130065848A1 (en) 2013-03-14
PL3210990T3 (pl) 2020-10-05
BR112012029913B1 (pt) 2021-02-02
KR20130041829A (ko) 2013-04-25
ZA201406381B (en) 2016-08-31
DK3210990T3 (da) 2020-03-23

Similar Documents

Publication Publication Date Title
IL290158A (en) Crystal structure of cyclosporin a, methods of preparation, and methods of using it
IL250824B (en) Certain amino-pyrimidines, their assemblies, and methods of using them
PL3210991T3 (pl) Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie
IL229419B (en) Heat-stable vaccines and methods for their preparation
EP2657188A4 (en) FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME
EP2530079A4 (en) PHENYL-C-GLUCOSIDE DERIVATIVES, PREPARATION METHODS AND USES THEREOF
IL222969A0 (en) Sweetener compositions and methods of preparing the same
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
PL2562172T3 (pl) Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania
IL225972A0 (en) Salts of cocuamine b, a method for their preparation and use
EP2581371A4 (en) PYRROLYL-SUBSTITUTED DIHYDROINDOL-2-ON DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USES THEREOF
EP2766375A4 (en) PREPARATION OF NEW FLUORIN COMPOUNDS, METHOD OF MANUFACTURING AND COMPOSITIONS MADE THEREOF
IL233238A (en) Sulphonylaminopyrrolidinone derivatives, their preparation and therapeutic use
EP2766183A4 (en) IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
IL232935B (en) Acamprosate preparations, methods of using them and combinations containing them
EP2701689A4 (en) PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF
EP2610257A4 (en) DIIMIDED DERIVATIVE OF BERBAMINE, MANUFACTURING METHOD AND ITS USE
SG11201405376TA (en) CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β, 5, 6β-TRIOL AND PREPARATION METHODS THEREOF
EP2626347A4 (en) DALFAMPRIDINPOLYMORPH AND THE PREPARATION AND USE THEREOF
EP2621490A4 (en) PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF
IL220859A0 (en) Alkyl-heterocycle-carbamate derivatives, their preparation and therapeutic application
GB201002278D0 (en) composition and method of preparation
AU2011905060A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
AU2010905320A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
HK1196109A (en) Iron-fiber composition, preparation and uses thereof